Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 198, Issue 10, Pages 1502-1513Publisher
OXFORD UNIV PRESS INC
DOI: 10.1086/592508
Keywords
-
Categories
Ask authors/readers for more resources
Background. Emerging research suggests that genetically distinct strains of Mycobacterium tuberculosis may modulate the immune system differently. This may be of importance in high-burden settings where >= 1 genetic group of M. tuberculosis confers significant morbidity. Methods. A dynamic mathematical model was constructed to evaluate how different degrees of cross-immunity among M. tuberculosis groups could affect epidemics of drug-resistant tuberculosis ( TB). Results. Simulated populations with immunogenically distinct TB strain groups experienced a heightened risk of drug-resistant TB, compared with populations without such strain diversity, even when the same rates of case detection and treatment success were achieved. The highest risks of infection were observed in populations in which HIV was prevalent. Drug-resistant strains with very low transmission fitness could still propagate in environments with reduced cross-immunity among different strain groups, even after common targets for case detection and treatment success are reached. Conclusions. It is possible that the propagation of drug-resistant strains could depend not only on the rate of development of resistance and the fitness of the drug-resistant strains but, also, on the diversity of the strains in the region. The risk of infection with drug-resistant strains could be amplified in locations where there is reduced crossimmunity between originating strain groups. This amplification may be most profound during the first few decades of TB treatment expansion.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available